Your browser doesn't support javascript.
Persistent cough and asthma-like symptoms post COVID-19 hospitalization in children.
Esmaeilzadeh, Hossein; Sanaei Dashti, Anahita; Mortazavi, Negar; Fatemian, Hossein; Vali, Mohebat.
  • Esmaeilzadeh H; Allergy Research Center, Shiraz University of Medical Sciences, P. O. Box 719335899, Shiraz, Iran. esmailzadeh_ho@yahoo.com.
  • Sanaei Dashti A; Department of Allergy and Clinical Immunology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. esmailzadeh_ho@yahoo.com.
  • Mortazavi N; Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Fatemian H; Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, P. O. Box 719335899, Shiraz, Iran. mortazavi_ne@yahoo.com.
  • Vali M; Allergy Research Center, Shiraz University of Medical Sciences, P. O. Box 719335899, Shiraz, Iran.
BMC Infect Dis ; 22(1): 244, 2022 Mar 12.
Article in English | MEDLINE | ID: covidwho-1736352
ABSTRACT
BACKGROUNDS Respiratory viruses are the main triggers of asthma. Coronavirus is shown to contribute to respiratory tract infections that can lead to prolonged cough and asthma.

OBJECTIVES:

Present study aimed to determine the risk of developing Persistent cough and asthma-like symptoms in hospitalized children due to COVID-19.

METHODS:

This prospective study was carried out in a tertiary referral center. During the COVID-19 pandemic, 69 hospitalized pediatric patients admitted with COVID-19 were observed from February 2020 to January 2021. Clinical and laboratory data were recorded, and after discharge, patients were followed and visited for cough and asthma evaluation one, 2 and 6 months later. Patients with asthma-like diagnoses in follow up defined as asthma-like groups, and patients without any sign of asthma were categorized as the non-asthma group. Asthma-like co-morbids and risk factors were evaluated and compared between the two groups.

RESULTS:

In follow-up, most of the COVID-19 hospitalized patients (N = 42) (58.5%) were not affected by asthma-like symptoms. 60.9% of the COVID-19 patients were male. The asthma-like group cases had a significantly familial history of asthma (63.0%), past medical history of asthma (33.3%), and Allergic rhinitis (85.2%). Rates of signs and symptoms during hospitalization were significantly higher in patients with COVID-19 and past medical history of asthma.

CONCLUSIONS:

We found an asthma-like prevalence of 41.5% in the cohort of COVID-19 hospitalized children. Family history of asthma and previous history of asthma and allergic rhinitis are risk factors for asthma-like after COVID-19 hospitalization. COVID-19 presentations are more severe in the asthma-like group.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Child / Humans / Male Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07252-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Child / Humans / Male Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07252-2